Bavarian Nordic A/S (BVNRY) Expected to Announce Quarterly Earnings on Wednesday

Bavarian Nordic A/S (OTCMKTS:BVNRY) is projected to release its earnings data on Wednesday, March 5th. Analysts expect Bavarian Nordic A/S to post earnings of $0.40 per share for the quarter.

Bavarian Nordic A/S Stock Down 3.0 %

Shares of OTCMKTS BVNRY opened at $7.72 on Monday. The firm’s 50-day moving average price is $8.60 and its 200-day moving average price is $10.00. The company has a market cap of $1.83 billion, a PE ratio of 11.19 and a beta of 1.68. Bavarian Nordic A/S has a 52-week low of $6.86 and a 52-week high of $14.60.

Bavarian Nordic A/S Company Profile

Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name.